Generic commercial insurance policies were designed for general businesses—not for companies operating in the highly regulated peptide industry. Here's why specialized coverage matters and what happens when you rely on the wrong policy.
PRIA Brokers
PRIA Brokers — Peptide Insurance Specialist
Every business needs insurance. That's not the question. The question is whether the insurance you have will actually respond when you need it.
For companies in the peptide industry—manufacturers, distributors, compounders, clinics, and telehealth platforms—the answer with generic commercial policies is often: not adequately, and sometimes not at all.
Standard commercial general liability (CGL) policies are designed for businesses like restaurants, contractors, and retail stores. They cover bodily injury and property damage caused by your business operations.
When you submit a claim involving a peptide product, you're likely to encounter:
**Pharmaceutical exclusions.** Most CGL policies specifically exclude "products intended for use as a pharmaceutical, drug, or supplement." Peptides—especially those with pharmaceutical applications—often fall squarely in this exclusion.
**Professional services exclusions.** If the claim involves any element of medical advice, compounding decisions, or technical consultation, the CGL policy will exclude it as a "professional service."
**FDA regulatory exclusions.** Many policies exclude costs arising from government investigations, regulatory proceedings, or recall mandates.
**Pollution exclusions.** Some policies treat chemical or biological agents—which could include peptide compounds—as "pollutants," excluding related claims entirely.
The result: you pay premiums for years, submit a claim when you actually need coverage, and discover that your policy excludes exactly the type of loss you're facing.
The peptide industry has a pattern of companies discovering their insurance gaps at the worst possible moment—during an active claim or regulatory inquiry.
By that point, it's too late to correct the coverage. Insurers won't add coverage retroactively. New policies won't cover claims that have already been made or circumstances already known. And defense costs, settlements, and regulatory penalties must come out of operating capital.
The financial math is stark:
Average pharmaceutical product liability defense cost: $200,000–$500,000
Average pharmaceutical product liability settlement: $500,000–$2,000,000+
Average FDA consent decree compliance cost: $500,000–$3,000,000
Average FTC penalty for unsubstantiated health claims: $1,000,000+
Against these figures, the difference in premium between a generic commercial policy and a specialized peptide insurance program is minimal.
A program designed for the peptide industry, like those placed by PRIA Brokers, is built from the ground up to address industry-specific risks:
Coverage is specifically written to include peptide products—whether FDA-approved, compounded, or research-use.
Industry-appropriate limits that reflect the actual exposure presented by pharmaceutical products, not retail merchandise.
Claims arising from professional advice, documentation errors, and technical representations are covered—not excluded as "professional services."
Legal defense and penalty coverage for FDA and FTC proceedings, which are specific risk factors for this industry.
Pays for the actual cost of recalling a product: notification, retrieval, destruction, and business interruption.
Protects the individuals managing your company from personal liability exposure arising from corporate decisions in a highly regulated environment.
Ask your current broker these questions:
1. Are peptide products specifically covered under my product liability policy?
2. Does my policy exclude pharmaceutical, drug, or biologic products?
3. Do I have E&O coverage for professional advice and documentation errors?
4. Is there regulatory defense coverage for FDA and FTC proceedings?
5. What are my recall coverage limits and trigger conditions?
6. Do my D&O limits address regulatory action against individual officers?
If your broker doesn't know the answers or the answers reveal gaps, it's time for a second opinion from a specialist.
PRIA Brokers works exclusively in the specialty insurance space, with deep expertise in the peptide and compounding pharmacy industries. We understand the regulatory environment, the product risks, and the coverage structures that actually respond when claims arise.
We're not generalists who occasionally see a peptide account. We're specialists who understand your business, your exposure, and the markets that will write your risk correctly.
Contact us today at (888) 998-7742 or info@priabrokers.com. We'll review your current coverage, identify gaps, and provide a competitive proposal for a program that actually protects your business.
PRIA Brokers specializes in coverage for peptide manufacturers, GLP-1 compounders, distributors, and suppliers. Compare quotes from A-rated specialty carriers.